The 2026 anxiety supplement stack
No supplement stack replaces therapy or medication for clinical anxiety disorders. What follows is a layered protocol for the more common situation: persistent everyday anxiety that you'd like to dial down without prescription medication, or alongside it with your prescriber's blessing. Each layer is built from supplements with at least small randomised-trial evidence, and each layer can stand on its own if you want to keep things simple.
How the stack is built
Anxiety is not one mechanism — it has at least four pharmacologically distinct levers that supplements can reach: GABAergic tone, serotonergic tone, the HPA-axis cortisol response, and magnesium status. The protocol below addresses one lever per layer so you can identify what's actually working for you and adjust accordingly. Add one layer at a time, give it 2 to 4 weeks at the recommended dose, and only progress if you genuinely feel a difference.
Layer 1 — Magnesium and L-theanine (foundation)
Magnesium glycinate
200–400 mg elemental magnesium, evenings, with food
Magnesium deficiency is common, sub-clinical, and reliably associated with elevated anxiety scores in observational data. Repletion in deficient adults produces small but consistent improvements on validated anxiety scales. The glycinate form is the right starting point — gentle on the gut at higher doses, and glycine itself has weak independent calming activity. Citrate and L-threonate are also reasonable, but glycinate is the lowest-friction choice.
L-theanine
100–200 mg, taken acutely when needed (alpha-wave EEG effect within 30–40 min)
An amino acid found naturally in tea leaves. The standardised pure-enantiomer form (Suntheanine is the most-studied) produces a distinctive calm-but-alert state — measurable as increased alpha-wave EEG activity within 30 to 40 minutes — without sedation. Useful before presentations, meetings, social events, or any acute stressor. No tolerance development. No interaction with serotonergic medications. The closest thing to a no-downside acute anxiolytic in the supplement world.
Layer 2 — Adaptogenic load reduction
Ashwagandha (KSM-66 or Sensoril)
300–600 mg/day standardised extract, divided AM and PM
The largest randomised-trial base for any adaptogen on stress and anxiety endpoints. KSM-66 is the most-studied extract; Sensoril is a reasonable alternative with higher withanolide concentration. Effects on perceived-stress scores and Hamilton anxiety ratings show up over 6 to 8 weeks and continue building through 12. Cortisol reductions are real but modest. Avoid in active hyperthyroidism, in pregnancy, and alongside thyroid medications without monitoring. Cycling is not necessary based on current evidence; if used continuously, retest TSH at 6 months.
Layer 3 — Targeted phytochemistry (only if Layers 1 + 2 are insufficient)
Saffron extract (Affron or equivalent)
28 mg/day standardised extract
One of the most surprising recent findings in the anxiety supplement literature is the consistency of saffron's effect on mild-to-moderate depressive and anxiety symptoms. Multiple meta-analyses now favour saffron over placebo at the trial-validated 28 mg/day dose, with effect sizes that approach SSRIs in head-to-head trials of mild-to-moderate cases. Mechanism likely involves serotonergic and dopaminergic modulation. The catch: it's a mild MAO-A inhibitor, so the same caution as the rest of this layer applies for serotonergic medication overlap.
Lemon balm (Melissa officinalis) extract
300–600 mg/day standardised extract
Modest GABAergic activity via mild GABA transaminase inhibition. Small RCTs in stressed adults and in adolescents with anxiety symptoms show small improvements in subjective stress and sleep quality. Useful as a daytime alternative to ashwagandha for users who find ashwagandha mildly stimulating. Generally very well tolerated.
Layer 4 — Sleep and circadian (because half of anxiety is sleep)
Glycine
3 g, 30–60 min before bed
Lowers core body temperature and improves subjective sleep quality at the 3 g dose validated in Japanese trials. Useful in users who fall asleep but wake feeling unrested. Stacks cleanly with the magnesium glycinate from Layer 1.
Melatonin (low dose)
0.3–1 mg, 30–60 min before desired sleep time
The vast majority of melatonin product doses on the US market are 5 to 10 mg — orders of magnitude above what physiological replacement requires. Lower doses (0.3 to 1 mg) match endogenous output and produce cleaner phase-shifting effects without the morning grogginess that high-dose melatonin causes. Use is for circadian timing, not nightly sedation.
Layer 5 — Targeted serotonin precursors (only with explicit clinician sign-off)
5-HTP and L-tryptophan are not part of this default stack. Both can produce useful effects in some users, but the drug-interaction risk is real and the failure mode is dangerous. If you're considering this layer, please read our 5-HTP vs L-tryptophan vs SAMe comparison and discuss with your clinician.
What to skip
- Kava — the only acute anxiolytic with hard RCT support, but the FDA hepatotoxicity advisory and EFSA risk assessment make it a hard no for routine use, despite some integrative-medicine enthusiasm.
- CBD products — the human RCT base for anxiety is much thinner than the marketing implies, doses required for clinical effect are typically 200 to 800 mg/day (not the 10 to 25 mg in retail products), and CYP3A4 / CYP2D6 interactions are real.
- "Adrenal fatigue" complexes — built around an unrecognised diagnosis. The included adaptogens may help; the framing is misleading.
- Generic "calm" gummies — typically combine sub-therapeutic doses of L-theanine, lemon balm, and chamomile in marketing-quantity amounts.
What to track
Pick one validated subjective scale (the GAD-7 is free and takes two minutes) and rate yourself weekly. Don't change two things at once; that's how supplement protocols become unfalsifiable. Don't over-dose; bigger isn't better here, and ashwagandha in particular has a flat dose-response curve above 600 mg/day.